Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Complement activation at the interface between adipocytes and cancer cells drives tumor progression
Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang, Hao Huang, Jian-Jun Wei, Mauricio Cuello-Fredes, Sumie Kato, Fernán Gómez-Valenzuela, Francoise Gourronc, Aloysius Klingelhutz, Daniela Matei
Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang, Hao Huang, Jian-Jun Wei, Mauricio Cuello-Fredes, Sumie Kato, Fernán Gómez-Valenzuela, Francoise Gourronc, Aloysius Klingelhutz, Daniela Matei
View: Text | PDF
Research Article Cell biology Oncology

Complement activation at the interface between adipocytes and cancer cells drives tumor progression

  • Text
  • PDF
Abstract

The omentum is the primary site of metastasis for ovarian cancer (OC). Interactions between cancer cells and adipocytes drive an invasive and prometastatic phenotype. Here we studied cancer cell–adipocyte crosstalk by using a direct coculture model with immortalized human visceral nondiabetic pre-adipocytes (VNPADs) and OC cells. We demonstrated increased proliferation, invasiveness, and resistance to cisplatin of cocultured compared with monocultured OC cells. RNA sequencing of OC cells from coculture versus monoculture revealed significant transcriptomic changes, identifying over 200 differentially expressed genes common to OVCAR5 and OVCAR8 cell lines. Enriched pathways included PI3K/AKT and complement activation. Lipid transfer into OC cells from adipocytes induced upregulation of complement C3 and C5 proteins. Inhibiting C3 or C5 reversed the invasive phenotype and C3 knockdown reduced tumor progression in vivo. Increased C3 expression was observed in omental implants compared with primary ovarian tumors and C3 secretion was higher in OC ascites from high-BMI versus low-BMI patients. C3 upregulation in OC cells involved activation of the ATF4-mediated integrated stress response (ISR). Overall, adipocyte–cancer cell interactions promoted invasiveness and tumorigenesis via lipid transfer, activating the ISR, and upregulating complement proteins C3 and C5.

Authors

Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang, Hao Huang, Jian-Jun Wei, Mauricio Cuello-Fredes, Sumie Kato, Fernán Gómez-Valenzuela, Francoise Gourronc, Aloysius Klingelhutz, Daniela Matei

×

Figure 8

C3 expression in patient tumors increases with contact with omentum and high body mass index.

Options: View larger image (or click on image) Download as PowerPoint
C3 expression in patient tumors increases with contact with omentum and ...
(A and B) Gene expression analysis by RNA-seq using TNMplot compares C3 (A) and C3A receptor 1 (C3AR1) (B) in human HGSOC tumors vs. normal ovarian tissue. (C) Gene expression analysis by RNA-seq compares C3 expression between primary tumors against metastatic implants (n = 31 paired specimens, GSE204748). The box-and-whisker plots show the median (line within box), IQR (upper and lower box bounds), and 1.5 times the IQR (whiskers). No outliers were found, except for a lower extreme of 7.03 for the metastasis group. (D and E) Kaplan-Meier overall survival curves determined by multivariate analysis by using combined expression levels of all complement-related genes in TCGA (D) and in the Australian ovarian cancer cohorts (E) by using the TOPP platform. (F and G) Representative images of IHC staining (F) and mean ± SD DAB mean intensity was calculated using Fiji DAB color deconvolution (G) of C3 expression in cancer cells in sections of paired primary and metastatic tumors from women with HGSOC (mean ± SD, n = 12 paired specimens). Intense C3 staining is noted in cancer cells adjacent to adipocytes in the omental metastases. Scale bar: 200 μm. (H) Measurements of C3 concentrations by ELISA in ascites of OC patients with BMI < 25 (n = 7) vs. BMI > 25 (n = 20). (I) Measurements of C3a concentrations by ELISA in ascites (n = 18) vs. plasma (n = 18) of paired samples from OC patients. **P < 0.01, ****P < 0.0001 by unpaired, 2-tailed Student’s t test (A–C, G, and H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts